Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Japanese Butterbur (Petasites japonicus) contains bioactive sesquiterpenes (petatewalide B, furanopetasin, bakkenolide IIIa) and phenolic compounds (petasiphenol, cimicifugic acid D) that inhibit mast cell degranulation, COX-2/iNOS expression, and leukotriene synthesis, conferring potent anti-allergic, anti-inflammatory, and photoprotective properties (PMID 16608208; PMID 26674157). A 2006 study in the Journal of Agricultural and Food Chemistry demonstrated that Japanese butterbur extract significantly inhibited Type I allergic responses by suppressing mast cell degranulation in a dose-dependent manner, while flavonoids from the plant activate HSF-1/Nrf2 pathways to protect against UVB-induced cellular damage (PMID 28566621).
Reported Benefits (Provisional)
Origin & History
Japanese Butterbur (Petasites japonicus), known as Fuki, is a perennial herbaceous plant native to Japan, Korea, and parts of China. It thrives in moist, shaded environments and is traditionally harvested in early spring. This botanical is valued in functional nutrition for its unique compounds that support respiratory and inflammatory responses.
Research Narrative (Provisional)
Shimoda et al. (2006) demonstrated in the Journal of Agricultural and Food Chemistry that Japanese butterbur extract and its isolated constituents inhibited Type I allergic mast cell degranulation, identifying specific active ingredients responsible for anti-allergic activity (PMID 16608208). Choi et al. (2016) isolated petatewalide B, a novel sesquiterpene from Petasites japonicus, and confirmed its significant anti-allergic properties in the Journal of Ethnopharmacology (PMID 26674157). Kim et al. (2017) published in Biological and Pharmaceutical Bulletin that flavonoids from P. japonicus exerted dual protective effects against UVB-induced apoptosis through activation of HSF-1-mediated heat shock proteins and Nrf2-activated heme oxygenase-1 (HO-1) pathways (PMID 28566621). Additionally, a combined phase 1 and 2 clinical trial by Noguchi et al. (2026) in BMC Veterinary Research evaluated butterbur shoot extract for clinical impact in dogs with oral melanoma, expanding its therapeutic applications beyond traditional use (PMID 41721401).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Dietary Fiber - Potassium - Magnesium - Petasin - Isopetasin - Flavonoids - Phenolic compounds - Pyrrolizidine alkaloids (PAs) (Note: Raw Butterbur contains PAs; extracts must be PA-free for safety).
Reported Mechanism (Provisional)
Japanese butterbur's anti-allergic effects are mediated by sesquiterpenes including petatewalide B and furanopetasin, which inhibit IgE-mediated mast cell degranulation and suppress histamine and leukotriene release through inhibition of calcium influx and 5-lipoxygenase (5-LOX) pathways (PMID 16608208; PMID 26674157). Phenolic constituents such as petasiphenol and cimicifugic acid D directly inhibit COX-2 and iNOS enzyme expression, reducing pro-inflammatory mediators prostaglandin E2 (PGE2) and nitric oxide (NO), while petasiphenol additionally inhibits DNA polymerase lambda and suppresses in vitro angiogenesis via VEGF pathway interference (PMID 14719082). Flavonoids from P. japonicus activate the HSF-1 transcription factor to upregulate heat shock proteins (HSP70, HSP27) and simultaneously induce the Nrf2/ARE pathway to enhance heme oxygenase-1 (HO-1) expression, providing dual cytoprotection against UVB-induced oxidative stress and apoptosis in skin cells (PMID 28566621). Bakkenolide IIIa and furanopetasin also modulate BMP-II receptor signaling by forming multiple hydrogen bonds with Cys94, upregulating BMP-2-mediated osteoblast differentiation relevant to bone health.
Clinical Narrative (Provisional)
Human clinical trial data for Petasites japonicus is extremely limited, with evidence primarily from preclinical animal studies. In ICR mice, 0.1-0.3% dietary butterbur extract for one week improved plasma lipids and hepatic antioxidant activity. Studies in RBL-2H3 cells and guinea pig models showed 70% ethanol extracts inhibited histamine release, leukotriene synthesis, and tracheal constriction. While one placebo-controlled trial for butterbur in allergic rhinitis is mentioned in literature, no specific numerical outcomes or sample sizes are available for P. japonicus.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.